Trial Profile
A retrospective study to evaluate Pazopanib effect as a new treatment option in patients with cutaneous angiosarcoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Haemangiosarcoma
- Focus Adverse reactions; Therapeutic Use
- 26 Apr 2017 New trial record